Health
What GLP-1 Drugs Actually Do Inside Your Body
GLP-1 receptor agonists did not start as weight loss drugs. Here is the biology behind Ozempic, Mounjaro and the hormone they mimic.
Jan 25, 2024
Loading
Search
Results
23 stories for“GLP-1”
Health
GLP-1 Side Effects and Who Should Not Take Them
Nausea is the least of it. Here is an honest look at GLP-1 side effects, the thyroid warning, pancreatitis and who is advised to avoid them.
Jul 10, 2024
Health
The GLP-1 Era: How Weight-Loss Drugs Changed Us
Semaglutide and tirzepatide went from diabetes treatment to celebrity shortcut to a genuine health story. What happens when one drug becomes a cultural moment.
Apr 20, 2024
Health
What GLP-1 Drugs Actually Cost in the UAE Right Now
Ozempic, Wegovy and Mounjaro are all prescribable in the UAE, but shortages and insurance gaps shape who can actually get them.
Mar 10, 2025
Health
Muscle Loss on GLP-1s: What the Evidence Really Shows
New body composition data compares lean mass loss on tirzepatide and semaglutide. Here is what is measured, and what remains unclear.
Jun 15, 2026
Health
GLP-1 Drugs Are Becoming More Than Weight Loss Medicine
Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025
Health
What Actually Happens When You Stop Taking a GLP-1
Trial data on stopping semaglutide shows most of the lost weight comes back within a year. Here is what the STEP 1 extension found.
May 15, 2024
Health
Mounjaro and Zepbound: The Case for Two Hormones at Once
Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024
Health
Retatrutide's Phase 3 Run Is Nearly Complete. The Numbers Are the Largest Yet
TRIUMPH-2 and TRIUMPH-3 read out in July, following TRIUMPH-1 in May. Across the programme the triple agonist has produced weight loss in a range no approved obesity drug has reached, with a filing due in early 2027.
Aug 11, 2026
Nutrition
The Mice Kept Eating Less and Put the Weight Back On Anyway. That Is the Interesting Part.
A Yale study found semaglutide switches the brain's hunger neurons on rather than off, and that those neurons are required for fat loss to last. Remove them and the mice ate just as little and regained the weight within fifteen days.
Aug 25, 2026
Health
Retatrutide: The Triple Agonist Still Proving Itself
Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026
Health
One Receptor, Two, or Three: Comparing Semaglutide, Tirzepatide and Retatrutide
Ozempic, Mounjaro and the drug that has not arrived yet are not three versions of the same thing. They hit different receptors, produce different results, and suit different people.
Aug 11, 2026
Health
Ozempic in a Tablet: What the Rebrand of Oral Semaglutide Actually Changes
Novo Nordisk folded Rybelsus into the Ozempic name in May and put a self-pay price on it. Getting a peptide to survive the stomach is a real achievement, but the tablet is not simply the injection in another form.
Aug 11, 2026
Health
Retatrutide's Third Receptor Is the Hormone That Raises Blood Sugar. Adding It On Purpose Is the Whole Idea
Semaglutide hits one receptor and tirzepatide hits two. The third one retatrutide adds is glucagon, which does the opposite of what a diabetes drug is supposed to do. It is also where the liver results and the safety questions both come from.
Aug 20, 2026
Health
Berberine and the 'Nature's Ozempic' Claim: What Evidence Shows
Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024
Health
The 2026 Guidelines Quietly Removed the Hurdles People Had to Clear Before Getting an Insulin Pump
Continuous monitoring is now recommended for adults with type 2 diabetes who are not on insulin at all, and the prerequisites for starting automated insulin delivery have been deleted rather than relaxed. Both changes are about access.
Aug 15, 2026
Health
What a Peptide Actually Is, and Why the Word Now Sells Almost Anything
Insulin is a peptide. So is Ozempic. So is the unlabelled vial someone is selling on Telegram. The word describes a chemical class, not a level of evidence, and that gap is where the market lives.
Aug 11, 2026
Nutrition
Eating the Same Meal in a Different Order Cut Post-Meal Glucose by More Than a Third
Identical food, identical calories, identical macronutrients. The only variable was what went in the mouth first, and glucose at sixty minutes fell by 36.7 per cent. It is the cheapest intervention in diabetes nutrition.
Aug 18, 2026
Health
Ozempic and Wegovy: What the Trials Actually Showed
Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.
Mar 13, 2024
Health
The Conversation About Fasting With Diabetes Should Happen Two Months Before Ramadan, Not During It
The IDF and Diabetes and Ramadan International Alliance stratify patients into low, moderate and high risk, and updated the calculator for 2026. The assessment is meant to happen six to eight weeks ahead, which is when almost nobody books it.
Aug 3, 2026
Nutrition
Fibre Is the Nutrient Almost Everyone Under-Eats, and Here Is What It Does
Most adults eat about half the fibre they need. The gap matters more than dieters realise, and closing it is not about bran.
May 22, 2024
Health
There Are Not Two Kinds of Diabetes, and Being Put in the Wrong Box Changes the Treatment
Type 1 and type 2 are the two everyone knows. LADA is regularly mistaken for type 2 in adults, and MODY is a single-gene condition that can sometimes be treated with a tablet instead of insulin. The label decides the therapy.
Jul 7, 2026
Health
Retatrutide Is Not Approved in Any Country. It Is Also for Sale in Most of Them
Lilly does not expect to file for approval until the first quarter of 2027. Search the drug's name today and you can have a vial by the weekend. The gap between those two facts is where the harm happens.
Aug 20, 2026
